Erowid Methylone Vault : Timeline

Modern humans must learn how to relate to psychoactives
responsibly, treating them with respect and awareness,
working to minimize harms and maximize benefits, and
integrating use into a healthy, enjoyable, and productive life.

Methylone (bk-MDMA)

Timeline

by Erowid

Oct 22, 1993		Methylone -- referred to as MDMA-ONE in his lab notes -- is first bioassayed by Alexander Shulgin, at 10 milligrams. 1 [Details] [More Info] Over the next nine months he and others in his research group work up to 300 mg (initial doses plus redoses).
Dec 12, 1996		The methylone synthesis is published in a 1996 patent, which mentions its potential as an antidepressant. 2
Sep 2001		First experience report of use of methylone submitted to Erowid.

References

Shulgin AT. Pharmacology Book 9. PDF page 96.
Jacob, Peyton, III, and Alexander T. Shulgin. Novel N-substituted-2-amino-3',4'-methylene-dioxypropiophenones. Neurobiological Technologies, Inc., assignee. Patent PCT/US96/09603. 12 Dec. 1996. Print.